Navigation Links
Study in Cell by Magen BioSciences Co-Founder David E. Fisher,Identifies New Roles in Skin Cancer Prevention for Key Tumor,Suppressor Protein

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 8, 2007 - Magen BioSciences, Inc., a specialty dermatology company, today announced the publication of a paper in the March 9, 2007 issue of the journal Cell by its co-founder and board member, David E. Fisher, M.D., Ph.D., that identifies two new functions for an important protein, p53, in the pigmentation of skin. Fisher's study shows that in addition to its function as a tumor suppressor in other cancers in the body, p53 also plays a key role in prompting the skin to tan in response to ultraviolet light from the sun. By promoting tanning, p53 deters the development of the skin cancer melanoma, which is increasing in incidence faster than any other cancer in the world.

Fisher's research also shows that p53 causes the production of an endorphin after ultraviolet exposure, and this may modulate sensation in the skin in a manner that influences behaviors, possibly including sun-seeking behaviors.

For Magen BioSciences, the study in Cell provides important proof of concept for the company's approach to identify and develop therapeutic treatments for pigmentation disorders.

"We know that people who tan easily or have dark pigmentation are far less likely to develop melanoma," said David Fisher, with the Dana-Faber Cancer Institute. "This study suggests that p53, one of the best-known tumor-suppressor proteins in our body, goes into action when skin cells experience UV exposure, prompting the skin to tan as a defensive mechanism against DNA damage and at the same time creating endorphins that may alter sensation or even behavior."

"Dr. Fisher's discovery of this new function for a well-known protein sheds new light on the mechanism and function of tanning," said Brian Gallagher, Ph.D., Magen's president and chief executive officer. "This discovery will help Magen BioSciences identify lead compounds and develop therapeutic treatments for disfiguring dermato
'"/>




Page: 1 2

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:7/29/2014)... , July 29, 2014  Neurocrine Biosciences, Inc. ... Company will report its second quarter 2014 financial results ... 2014.  Neurocrine will then host a live conference call ... a Company update Thursday morning, August 7, 2014 at ... Participants can access the live conference call by ...
(Date:7/29/2014)... -- Sysmex America, Inc., a global leader in medical diagnostic ... exhibit booth during the American Association for Clinical ... in Chicago , July 27 through ... excited to exhibit at AACC this year, because it,s ... continue the dialogue on how to best meet the ...
(Date:7/29/2014)... , July 29, 2014 Apex Medical Corporation ... and Pressure Area Care sectors, announces that it is appealing ... in Germany that found ... Apex notes that it has initiated invalidity challenges against various ... efforts in counterattacking against trivial and junk patents. ...
Breaking Medicine Technology:Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 2New Product Offerings Highlight Sysmex's Presence at 2014 AACC in Chicago 3Apex Continues Fighting Against Patents to Free Up Competition 2
... CPhI Worldwide and connected events - the global pharma ingredients and ... - 15 October for its 20th staging. , The co-located ... technology events are joined for 2009 under the Where Pharma ... The new platform markedly reflects the notable convergence of the pharma ...
... (Nasdaq: DYNT ) today announced the appointment of Douglas ... research and development, replacing Ronald Hatch, who has retired. , ... said Kelvyn Cullimore Jr., chairman and president of Dynatronics. "His ... operation as well as our research and development efforts here ...
Cached Medicine Technology:CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 2CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 3Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development 2
(Date:7/29/2014)... of America (GSA) the nation,s largest interdisciplinary ... chosen Corinna E. Lckenhoff, PhD, of Cornell University as ... B. Baltes Foundation Award in Behavioral and Social Gerontology. ... career contributions in behavioral and social gerontology. Individuals who ... are eligible. The award is given by GSA in ...
(Date:7/29/2014)... 2014 The report “Filling Equipment ... (Rotary, Volumetric, Aseptic, Net Weight), Process (Manual, Semi-Automatic, ... Global Trend & Forecast to 2019”, defines the ... beverage, pharmaceutical, and cosmetic segments with analyses and ... these segments, in terms of value. It also ...
(Date:7/29/2014)... July 29, 2014 - What if ... source? That’s the big public health question being addressed ... risk program developed by Principled Strategies . SafeUseNow ... be part of The Hive at the ... The Hive is a community of exceptional startups and ...
(Date:7/29/2014)... -- With the increasing use of electronic medical ... growing demand for a computerized version of the ... States. In a new study, researchers from the ... Institute report that substantial work lies ahead to ... guidelines into computerized prompts for physicians, but the ...
(Date:7/29/2014)... Reseda, Calif (PRWEB) July 29, 2014 ... , The Discovery House recently participated in a community ... Valley. The group of volunteers partnered with the San ... to individuals in need. , The San Fernando Valley ... individuals and families. The mission's Family Emergency Shelter provides ...
Breaking Medicine News(10 mins):Health News:Löckenhoff earns GSA's 2014 Baltes Foundation Award 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 2Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 3Health News:Filling Equipment Market worth $8 Billion by 2019 - Report by MarketsandMarkets 4Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 2Health News:SafeUseNow Selected to Showcase at TEDMED Hive 2014 3Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 2Health News:Study: Pediatric preventive care guidelines need retooling for computerized format 3Health News:The Discovery House Employees Volunteer at Local Rescue Mission 2Health News:The Discovery House Employees Volunteer at Local Rescue Mission 3
... News) -- It seems that Americans really can be in ... visited five car shows in Arizona and conducted interviews with ... found that those with an especially strong attachment used pet ... In addition, some people used this emotional connection to ...
... of Medicine in St. Louis have learned why changes in ... the parasite Toxoplasma gondii . The answer has likely ... Toxoplasma and many other parasites. In a ... show that the ROP18 protein disables host cell proteins that ...
... Dec. 28 (HealthDay News) -- Preteens with conduct disorders are much ... they are teens, finds a new Canadian study. It followed ... 13 at the start of the study. Those who stole, ... likely to sell illicit drugs, nine times more likely to join ...
... Reporter , TUESDAY, Dec. 28 (HealthDay News) -- Sheri Foote ... have. Foote, 43 and a Denver resident, was first ... about age 21. "I knew I had a family history ... good thing to do," Foote recalled. Her cholesterol "was ...
... PAUL, Minn. Epilepsy, a common and serious neurologic disorder that ... and funding for research it deserves, according to an editorial ... issue of Neurology, the medical journal of the ... surveillance, or ongoing collection of data on newly diagnosed epilepsy, ...
... [Brown University] A novel potential therapy based on a ... in mice who have the same genetic mutation as boys ... a paper published online Dec. 27 in the Proceedings ... Dystrophy is a fatal genetic mutation in about one of ...
Cached Medicine News:Health News:Love of Possessions Can Run Deep, Study Shows 2Health News:Protein helps parasite survive in host cells 2Health News:Woman Struggles to Control Cholesterol 2Health News:Researchers: Pay more attention to epilepsy 2Health News:Human protein improves muscle function of muscular dystrophy mice 2
... Chalam 15° Prism are designed ... are recommended for tractional retinal ... Rhegmatogenus retinal detachment. They can ... and other midperipheral laser applications. ...
... The High-Mag 1.5x ... internal limiting membrane peeling ... optic nerve neurotomy, sheathotomy ... traditional macular edema and ...
... visualization of virtually the entire retina including ... of the lens on the eye. It ... giant retinal tears, diagnosing and treating anterior ... retina in a vitreous cavity filled with ...
... higher magnification and increased stereopsis, ... suited for detailed visualization to ... Retinal is ideal for vitrectomy ... peeling in proliferative vitreoretinopathy extending ...
Medicine Products: